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Summary
Signaling by extracellular Hedgehog (Hh) molecules is
crucial for the correct allocation of cell fates and pat-
terns of cell proliferation in humans and other organ-
isms [1, 2]. Responses to Hh are universally mediated
by regulating the activity and the proteolysis of the Gli
family of transcriptional activators such that they in-
duce target genes only in the presence of Hh [1, 3].
In the absence of Hh, the sole Drosophila Gli homolog,
Cubitus interruptus (Ci), undergoes partial proteolysis
to Ci-75, which represses key Hh target genes [4]. This
processing requires phosphorylation of full-length Ci
(Ci-155) by protein kinase A (PKA), casein kinase 1
(CK1), and glycogen synthase kinase 3 (GSK3), as well
as the activity of Slimb [5–7]. Slimb is homologous to
vertebrate b-TRCP1, which binds as part of an SCF
(Skp1/Cullin1/F-box) complex to a defined phospho-
peptide motif to target proteins for ubiquitination and
subsequent proteolysis [8–10]. Here, we show that
phosphorylation of Ci at the specific PKA, GSK-3, and
CK1 sites required in vivo for partial proteolysis stim-
ulates binding to Slimb in vitro. Furthermore, a consen-
sus Slimb/b-TRCP1 binding site from another protein
can substitute for phosphorylated residues of Ci-155
to direct conversion to Ci-75 in vivo. From this, we
conclude that Slimb binds directly to phosphorylated
Ci-155 to initiate processing to Ci-75. We also explore
the phosphorylated motifs in Ci that are recognized
by Slimb and provide some evidence that silencing of
Ci-155 by phosphorylation may involve more than
binding to Slimb.
Results and Discussion
Slimb Binds In Vitro to Ci Phosphorylated at PKA,
CK1, and GSK3 Sites
The mechanism and consequences of Hh signaling have
been studied extensively in the developing Drosophila
wing imaginal disc, where Hh, secreted from posterior
compartment cells, induces a strip of nearby, responsive
anterior cells (AP border cells) to express a small set of
target genes, including decapentaplegic (dpp), that sub-
sequently pattern the developing wing [3, 11–13]. In an-
terior cells far from Hh, Ci-155 is processed slowly to
Ci-75, which crucially represses potential Hh target
genes, including hh itself and dpp, to ensure that they
are not ectopically expressed [4, 11, 12]. Even low-level
Hh signaling at the AP border blocks Ci-75 production,
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further activates Ci-155 in a dose-dependent manner
by facilitating its nuclear accumulation and potentially
also by modifying its binding partners in the nucleus [3,
12, 14, 15]. Because formation of Ci-75 requires both
Ci-155 phosphorylation and the activity of Slimb, it was
proposed that Slimb might promote partial proteolysis
of Ci-155 by directly binding to phosphorylated Ci-155
and catalyzing its ubiquitination [6]. However, despite
some support for this hypothesis [14, 16], Ci-155 con-
tains no obvious consensus binding site for Slimb/b-
TRCP1, there are only two well-studied examples where
proteasomal degradation of a ubiquitinated protein is in-
complete (NF-KB precursors, p100 and p105), and ubiq-
uitinated Ci-155 has not been detected when Ci-155 is
stabilized by inhibiting the proteasome [14, 16, 17].
To determine whether Slimb can bind to Ci in a manner
dependent on phosphorylation, we used a purified GST
fusion protein that includes the key phosphorylation
sites of Ci [7]. This GST-Ci protein undergoes a signifi-
cant mobility shift in SDS polyacrylamide gels when
phosphorylated by PKA and CK1 together and an even
greater shift if GSK3 is also included (Figure 1B). GST-Ci
bound more avidly than GST alone to 35S-labeled full-
length Slimb produced by in vitro translation in a reticu-
locyte lysate and to HA-tagged full-length Slimb from
crude extracts of transiently transfected Drosophila
Kc cells (Figure 1B). This binding was reproducibly in-
creased by using PKA together with CK1, and to a
much greater extent by using all three protein kinases
to phosphorylate GST-Ci prior to the binding assay (Fig-
ure 1B). The synergistic contribution of GSK3 was clear-
est in the HA-Slimb binding assay, and so we used this
assay to investigate the characteristics of Ci binding to
Slimb further.
Three PKA sites (‘‘P1-3’’), the neighboring three PKA-
primed CK1 sites (‘‘C1-3’’) and the two adjacent PKA-
primed GSK3 sites (‘‘G2,3’’) are required for Ci-155 to
be converted to Ci-75 in Drosophila embryos and wing
discs [5, 7, 18–21]. When the serine residues at these
PKA, CK1, or GSK3 sites were replaced with alanines
to produce P1-3A, C1-3A, and G2,3A (Figure 1A), we
no longer saw any significant stimulation of binding of
GST-Ci to HA-Slimb by any combination of PKA, CK1,
and GSK3 (Figure 1C). Thus, strong binding of HA-Slimb
to a Ci fragment in vitro requires the same protein ki-
nases and the same phosphorylation sites that are re-
quired in vivo to convert Ci-155 to Ci-75.
A Consensus Slimb Binding Site Restores
Conversion of Ci-155 to Ci-75 In Vivo
We then tested whether a defined, minimal Slimb bind-
ing site from another protein could direct processing
of Ci-155 to Ci-75. b-catenin is a prototypical substrate
for the b-TRCP1 SCF complex, in which a dually phos-
phorylated motif (DpSGIHpS, where pS stands for phos-
phoserine) is the critical recognition element for binding
[9, 10]. This motif is conserved in Drosophila b-catenin
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111Figure 1. Phosphorylation Stimulates Bind-
ing of GST-Ci to Slimb In Vitro
(A) Amino acids 834–899 of Ci highlighting the
three PKA sites and adjacent PKA-primed
GSK3 and CK1 sites (boxed residues), to-
gether with changes engineered into GST-Ci
proteins. Phosphorylation sites are color
coded as PKA (red), PKA-primed and CK1-
primed CK1 (dark blue), PKA-primed and
GSK3-primed GSK3 (green), CK1-primed
GSK3 or GSK3-primed CK1 (orange), and po-
tential CK1 sites deviating from an optimal
consensus (light blue).
(B) A pull-down assay was performed be-
tween GST or GST-Ci phosphorylated with
the indicated protein kinases and in vitro-
translated 35S-Slimb (left; autoradiograph) or
HA-Slimb from a Kc tissue-culture cell extract
(right; HA antibody western blot). GST pro-
teins were visualized by western blot, with ar-
rows indicating phosphorylated forms of al-
tered mobility (lower panels).
(C and D) Binding of HA-Slimb to GST-Ci (WT)
and GST-Ci variants listed in panel (A), show-
ing GST-Ci proteins (lower panels) and bound
HA-Slimb (top panels) visualized by western
blot. The relative intensities of HA-Slimb
bands are indicated, with a value of 1.0 as-
signed to the amount of HA-Slimb bound to
each of the unphosphorylated GST-Ci pro-
teins.(Armadillo), and Armadillo proteolysis depends on both
this sequence and Slimb activity [6, 22]. Hence, we ex-
pect the motif also to serve as a direct binding site
for Slimb, the Drosophila homolog of b-TRCP1. To test
whether this consensus Slimb/b-TRCP1 binding motif
could influence the fate of Ci, we altered Ci sequence
so that phosphorylation of PKA site 2 would theoretically
prime three consecutive phosphorylations at GSK3 sites
to produce a DpSGIHpS motif (‘‘SL’’ in Figure 1A). We
additionally altered PKA sites 1 and 3 to alanine resi-
dues in order to prevent the normal phosphorylation of
Ci from directing conversion to Ci-75. These PKA site
changes alone (‘‘P1,3A’’) and a DpSGIHpS-motif variant,
in which the first or third residue is changed to alanine
(‘‘SLD’’ and ‘‘SLG’’), were also introduced into GST-Ci
molecules as controls to assess the function of the
Slimb consensus binding motif (Figure 1A).
GST-Ci-SL was extensively phosphorylated by the
combined action of PKA and GSK3 in vitro, producing
a greater mobility shift than observed for GST-Ci-WT
(Figure 1D). Furthermore, unlike GST-Ci-WT and GST-
Ci-P1,3A, GST-Ci-SL bound strongly to HA-Slimb when
phosphorylated by only PKA and GSK3. PKA and GSK3
altered the mobility of GST-Ci-SLD to a similar extent
but did not enhance binding to HA-Slimb (Figure 1D).
Thus, the Slimb consensus site engineered into Ci is
functional and directs Slimb binding in vitro with an ap-
parent avidity similar to that seen for fully phosphory-
lated wild-type Ci.
The same alterations were engineered into full-length
UAS-Ci transgenes that encoded HA and FLAG tags atthe amino terminus and a Myc tag at the carboxy termi-
nus of Ci to produce Ci-WT, Ci-SL, Ci-P1,3A, Ci-SLD,
and Ci-SLG. Conversion of these Ci variants to Ci-75
was assayed in two ways. First, expressed proteins
were assayed by western blot with HA or FLAG antibody
to visualize tagged Ci-155 and Ci-75 proteins. This
was done in extracts of 5–8-hr embryos expressing the
UAS-Ci transgenes under control of a ptc-GAL4 driver
that leads to expression only in cells that normally ex-
press Ci (Figure 2A), in extracts of wing discs expressing
UAS-Ci transgenes under control of C765-GAL4, which
drives expression evenly throughout the wing disc (Fig-
ure 2A), and in extracts ofDrosophila Kc cells transiently
transfected with the transgenes under control of an ac-
tin-5C promoter (data not shown). The results were the
same in each circumstance. Ci-WT and Ci-SL produced
both tagged Ci-155 and Ci-75 proteins, whereas Ci-
P1,3A, Ci-SLD, and Ci-SLG produced only Ci-155 (Fig-
ure 2A). Furthermore, coexpression of a constitutively
active mouse PKA catalytic subunit (mC*) in wing discs
increased the proportion of Ci-75 produced by Ci-WT
and Ci-SL (Figure 2A), consistent with a role for PKA in
promoting phosphorylation of Slimb binding sites in
both proteins, but did not result in any detectable
Ci-75 from Ci-SLD.
The second assay for Ci-75 production measures
Ci-75 by its ability to repress transcription of ahh-lacZ re-
porter gene [23]. Thus, Ci-155 from a wild-type Ci trans-
gene is converted to Ci-75 and represses hh-lacZ in pos-
terior wing-disc clones that are unable to transduce a Hh
signal because they lack activity of Smoothened (Smo)
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(A) Western blots with HA antibody to probe HA immune precipitates of extracts from embryos (left) and crude extracts from wing discs (right)
expressing the indicated HA-tagged Ci transgenes, with or without the constitutively active mouse PKA catalytic subunit gene, mC*. Ci-75 (ar-
rows) migrates on top of a weak background band in each case and just above (left) or below (right) a strong background band (horizontal lines).
The ratio of Ci-75 to Ci-155 band intensities after subtraction of background is shown for each lane (right; average of two such blots).
(B) smo mutant clones (lacking GFP, green) were generated in wing discs expressing the indicated transgenes under the control of C765-GAL4.
hh-lacZ (red) expression in the posterior (right) is repressed only by Ci-WT and Ci-SL and selectively in smo mutant clones.
(C) hh-lacZ (red) is not repressed by Ci-WT or Ci-SL in smo pka double-mutant clones (Ca and Cb) or smo slimb double-mutant clones (Cc and Cd),
marked in each case by lack of GFP (green). In (Cc) and (Cd), hh-lacZ is absent from two types of clones that express GFP (smo FRT40A/smo
FRT40A; FRT82B slimb C765 hh-lacZ/FRT82B UbiGFP and smo FRT40A/UbiGFP FRT40A; FRT82B UbiGFP/FRT82B Ubi-GFP).(Figure 2B). Ci-SL also repressed hh-lacZ specifically in
posterior smo mutant clones, showing that Ci-SL can
be converted to a transcriptional repressor and that
this conversion occurs only in the absence of Hh signal
transduction (Figure 2B). Neither Ci-P1,3A nor Ci-SLD re-
pressed hh-lacZ in posterior smo mutant clones, con-
firming that conversion of Ci-SL to the Ci-75 repressor
depends on its Slimb consensus binding site (Figure 2B).
Generation of this binding site should require PKA and
GSK3 activity, and its function is expected to require di-
rect recognition by Slimb. We found that Ci-SL, like Ci-
WT, does not repress hh-lacZ in posterior smo mutant
clones if PKA activity is also eliminated or if these cells
also lack normal Slimb activity (Figure 2C). Thus, inser-
tion of a consensus Slimb binding site into a Ci derivative
that cannot otherwise be converted into Ci-75 restoresprocessing; processing to Ci-75 depends on both Slimb
activity and phosphorylation of the Slimb binding site,
and it is blocked by Hh signaling.
Slimb Binding Sites in Ci
We then used binding assays to search for the direct
Slimb recognition elements in Ci because no estab-
lished Slimb/b-TRCP consensus binding sites are ap-
parent in the sequence of Ci or Gli proteins. Each of
the three PKA sites in Ci is required for detectable pro-
cessing to Ci-75 in Kc tissue-culture cells [18], and so
we first tested whether each site contributes to Slimb
binding in vitro. Phosphorylation-dependent binding of
GST-Ci to HA-Slimb was reduced substantially by loss
of PKA site 1 (P1A) or site 3 (P3A) and eliminated by
loss of PKA site 2 (P2A) (Figure 3B). PKA sites 2 and 3
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for Slimb Binding
(A) Amino acids 834–899 of Ci color coded as
in Figure 1A, together with variants used in
Slimb binding assays. Potential Slimb bind-
ing sites are indicated by bars (bottom) that
arecoloredred [(D/pS)XXpS,centeredonPKA
sites], green (pSXXpSpS, including GSK3
sites), dark blue (pSpSXXpS, comprising
only strict consensus CK1 sites), light blue
[pS(pS/pT)XXpS, including nonconsensus
CK1 sites], and black [(D/pS)(pS/pT)XXX(pS/
pT)].
(B and C) GST-Ci variants shown in (A) were
phosphorylated by the indicated protein
kinases and incubated with HA-Slimb from
Kc cell extracts. Proteins brought down with
glutathione beads were blotted with HA anti-
body (upper panels) and GST antibody (lower
panels). In each case, results for GST-Ci var-
iants are presented alongside the internal Ci-
WT control tested strictly in parallel. Band in-
tensities corresponding to bound HA-Slimb
are indicated (after subtraction of back-
ground) for each lane relative to wild-type
GST-Ci with no phosphorylation (fixed at 1.0)
for that experiment.prime GSK3 sites. Those GSK3 sites, which are required
for Slimb binding (Figures 1A and 1C), can in turn prime
further phosphorylation by CK1 of the second serine in
the motif pSGSK3RRSpSPKA. If that second serine is re-
placed with an acidic residue (D, to form SRRDS, ‘‘DS’’
in Figures 3A and 3B), binding to Slimb is still markedly
stimulated by phosphorylation, but this stimulation is
lost if the GSK3 sites are also altered (ARRDS, ‘‘DS
G2,3A’’ in Figures 3A and 3B). Thus, the GSK3 sites are
not required simply to prime further phosphorylation
by CK1. When the PKA-primed GSK3 sites (and the sin-
gle GSK3-primed GSK3 site) were changed to glutamate
residues (‘‘G2,3E’’ in Figure 3A), binding of GST-Ci to
HA-Slimb was stimulated by combined PKA and CK1
phosphorylation and was not further enhanced by
GSK3 (Figure 3C). Similar properties were observed if,
in addition, the serine residues preceding PKA sites 2
and 3 were changed to aspartate (‘‘DS G2,3E’’ in Figures
3A and 3C). Thus, acidic-residue replacements can at
least partially mimic the contribution of phosphorylated
PKA-primed GSK3 sites to Slimb binding, and thoseGSK3 sites are likely recognized directly by Slimb, rather
than being required simply to prime further phosphory-
lation of Ci. Although replacement of GSK3 sites with
acidic residues did reduce maximal binding to Slimb in
vitro, this Ci variant (G2,3E) was processed to Ci-75 effi-
ciently enough to repress hh-lacZ substantially in poste-
rior smo mutant wing-disc clones (Figure S1 in the Sup-
plemental Data available online).
In contrast to the results with GSK3 sites, replacement
of all three PKA-primed CK1 sites (and the two predicted
CK1-primed CK1 sites) with acidic residues (‘‘C1-3E’’ in
Figure 3A) abolished any stimulation of HA-Slimb bind-
ing by phosphorylation of GST-Ci, even in the sequence
context RRDSXXE (‘‘DS C1-3E’’ in Figures 3A and 3C),
where a potential role for CK1 sites in priming phosphor-
ylation by GSK3 is eliminated. The C1-3E variant also
was not converted to Ci-75 repressor in wing discs
(Figure S1). These properties may reflect a defect in
direct recognition by Slimb of glutamates in place of
CK1-site phosphoserines or a defect in priming further
phosphorylation. Several serine and threonine residues
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[pS/pT]XX[S/T] consensus but may nevertheless be
phosphorylated by CK1 after PKA and CK1 priming
[24]. Altering five such residues to alanine, alone (‘‘NC-
A’’) or together with consensus CK1-primed CK1 sites
(‘‘CC/NC-A’’), eliminated all phosphorylation-dependent
binding to HA-Slimb (Figures 3A and 3B). The most
C-terminal of these potential CK1 sites would not be
expected to prime further phosphorylation, and their
requirement therefore suggests they are recognized
directly by Slimb.
We cannot readily determine whether the PKA sites
and PKA-primed CK1 sites are, as argued above for
GSK3 sites and distal CK1-primed CK1 sites, directly
recognized by Slimb. However, the evident contribution
of each PKA site to Slimb binding (Figure 3B) implies that
each must nucleate at least one direct Slimb binding
site. Surrounding the three PKA sites there are two types
of motifs that are related to previously recognized or
postulated Slimb/b-TRCP binding motifs (DSGXXS,
DSGXXXS, TSGXXS, EEGXXS, DDGXXD, and DSGXXL)
[17, 25–29]. First, the six-amino-acid motif (D/pS)(pS/
pT)(Q/Y)XX(pS/pT) might be created in three places if
phosphorylation occurs, as we suspect, at some non-
consensus sites (black bars, Figure 3A). These motifs
most closely resemble the b-TRCP1 binding site postu-
lated for p100 (DpSAYGpS) [17], but the presence of glu-
tamine or tyrosine at the third position in place of glycine
in the ideal consensus would be expected to reduce
binding by more than an alanine substitution [10]. Sec-
ond, many five-amino-acid motifs are created in which
two acidic residues (DpS, pSpS, or pSpT) are separated
from a phosphorylated residue (pS or pT) by only two
amino acid residues (colored bars, Figure 3A). Four
of these eight motifs include a glutamine at the third po-
sition. However, this residue does not appear to be in-
strumental in Slimb binding because substitution with
alanine (‘‘Q1-3A’’) has little effect (Figures 3A and 3B).
On the basis of the crystal structure of b-TRCP1, it is
hard to predict the affinity of the designated five-
Figure 4. A Consensus Slimb Binding Site Does Not Suffice to Si-
lence Ci-155
(A–D) The indicated Ci transgenes were expressed in wing discs,
and activation of the Hh target gene reporter ptc-lacZ was assessed
by staining for b-galactosidase activity (blue).
(E–H) Full-length Ci-155 transgene products were stained with an
antibody to the C-terminal Myc epitope tag (red). Ci-SLD behaved
exactly like Ci-P1,3A in these assays. Anterior is to the left, and dor-
sal is up.amino-acid motifs for Slimb, but it is likely to be lower
than for any of the motifs cited above [10]. Regardless
of which precise motifs contribute most significantly to
Slimb binding, it is clear from our mutational analysis
that Ci must be highly phosphorylated over a region
spanning almost sixty amino acid residues to generate
several suboptimal binding sites that must collaborate
to provide physiologically significant affinity for Slimb.
This follows a precedent established for degradation
of the yeast cell-cycle regulator Sic1 by binding of the
SCFCDC4 complex to multiple low-affinity phosphode-
grons [30]. The requirement for extensive Ci phosphory-
lation could account for the essential role of the scaf-
folding protein Cos2 in facilitating phosphorylation and
for the relatively slow conversion of Ci-155 to Ci-75
seen in vivo [4, 31].
Regulation of Ci-155 Activity by Slimb
We have shown that Slimb binding can promote conver-
sion of Ci-155 to Ci-75 repressor. This is a crucial role for
Slimb and Ci phosphorylation in vivo because it keeps
the key target gene dpp repressed in anterior wing-
disc cells away from the AP border [12]. However, Ci-
155 is only slowly converted to Ci-75 in anterior cells,
so it is also imperative that Ci-155 activity is held in
check prior to its partial proteolysis [3, 4]. We therefore
tested whether the consensus Slimb binding site in-
serted into Ci-SL was effective at silencing Ci-155 activ-
ity. The ptc-lacZ reporter gene requires Ci-155 to be ac-
tivated [12]. It is normally expressed only at the AP
border, but it is ectopically activated in posterior cells
if a wild-type Ci transgene is expressed evenly through-
out the wing disc (Figure 4A). This selective activation in
Hh signaling territory reflects both stabilization and acti-
vation of Ci-155 by Hh [12]. By contrast, Ci-P1,3A and Ci-
SLD activate ptc-lacZ strongly in both anterior and pos-
terior cells (Figure 4B), indicating high activity of Ci-155
even in the absence of Hh, as has been seen previously
for Ci variants lacking PKA, CK1, or GSK3 sites [5, 7, 18].
Surprisingly, Ci-SL also induced ptc-lacZ in both ante-
rior and posterior cells, albeit more weakly than Ci-
P1,3A and Ci-SLD (Figure 4C).
We also examined the levels of Ci-155 corresponding
to Ci-SL and other variants by staining wing discs for the
Myc epitope attached to the C terminus of each trans-
gene product. Myc staining was highest in posterior
and AP border cells for Ci-WT (Figure 4E), as expected,
reflecting stabilization of Ci-155 by Hh, whereas Myc
staining was extremely high and uniform for Ci-P1,3A
and Ci-SLD (Figure 4F). Surprisingly, Myc staining of
Ci-SL was higher in anterior cells than posterior cells
(Figure 4G) even though we have established that
Ci-SL is converted to Ci-75 only in the absence of Hh sig-
naling. This suggests that Ci-SL is not proteolyzed in an-
terior cells as efficiently as Ci-WT, whether this is by
conversion to Ci-75 or by other means [15, 16]. The ab-
errant accumulation of full-length Ci-SL in anterior cells
might in turn be responsible for the induction of ptc-lacZ
in these cells, especially if Ci-155 molecules accumulate
in excess over their stoichiometric binding partners
Cos2 and Su(fu), which normally limit Ci-155 activity
[3]. However, the consequences of increased Ci-155
concentration cannot be safely predicted [5, 7, 15, 21].
Indeed, when we examined another Ci variant, Ci-DS,
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a Hh signal (Figure S1), we also observed higher Myc
levels in anterior cells than in posterior cells, but Ci-DS
activated ptc-lacZ only in posterior cells (Figures 4D
and 4H). Thus, induction of ptc-lacZ in the absence of
Hh by Ci-SL may indicate a distinct role of phosphoryla-
tion in limiting the specific activity rather than the prote-
olysis of Ci-155, a role for which a single consensus
Slimb binding site is not an adequate substitute.
In summary, we have found that processing of Ci-155
to Ci-75 is initiated by direct binding of Slimb to Ci-155
molecules that have been extensively phosphorylated
by PKA, GSK3, and CK1. This presumably leads to ubiq-
uitination of Ci-155 and its partial proteolysis by the pro-
teasome, generating a transcriptional repressor that
plays a key developmental role in cells that are not ex-
posed to Hh. Whether phosphorylation also prevents
Ci-155 from activating transcription through an addi-
tional mechanism remains to be explored, as does the
mechanism by which proteolysis of Ci-155 is limited to
preserve its N-terminal domains as Ci-75.
Experimental Procedures
Mutagenesis and Cloning
Constructs for Drosophila germline transformation and tissue-
culture cell transfection were made with Gateway Technology (Invi-
trogen). The cDNAs of ci and slimb were inserted into pENTR-D/
TOPO via ‘‘topo cloning.’’ The destination vector used for germline
transformation is pTFHWM, which contains pUASt regulatory ele-
ments and encodes both a composite N-terminal Flag/HA tag and
a C-terminal Myc tag (www.ciwemb.edu/labs/murphy/Gateway%
20vectors.html). The destination vector used for tissue-culture
transfection, pAFHWM, differs only in that it contains an actin5C
promoter. pGEX2T-Ci685-920, described previously [7], was used to
make the GST-Ci fusion proteins. Mutations were made in pENTR-D/
TOPO-Ci and pGEX2T-Ci with the QuikChange Site-Directed Muta-
genesis Kit (Stratagene), and products were sequenced in their
entirety.
Kc Cell Extracts
Cells were cultured at 25ºC in Schneiders Drosophila media + 5%
FBS + 1% Penicillin-Streptomycin (GibcoBRL). Five 100 mm plates
were seeded with 1 3 107 cells in a volume of 10 ml of media and
were allowed to adhere overnight. Three to four hours prior to trans-
fection, cells were given fresh media. Ten micrograms of pAFHWM-
Slimb (or pAFHWM-Ci) was transfected by using the standard cal-
cium phosphate protocol, and after 24 hr, cells were given fresh
media. Cells were allowed to express for approximately another
36 hr and were then lysed in 3 ml lysis buffer (50 mM Hepes,
pH 7.5, 0.2mM EDTA, 250 mM NaCl, 50 mM NaF, 0.5 mM NaVO3,
0.5% NP-40, 1 mM DTT, protease inhibitors [Mini Complete,
Roche]).
In Vitro Phosphorylation and GST Pull-Down Assay
Approximately 200 ng of GST-Ci protein was bound to glutathione
sepharose beads in GSK3 buffer from NEB (20 mM Tris-HCl
[pH 7.5], 10 mM MgCl2, 5 mM DTT) for 1 hr at 4ºC in a volume of
100 ml. Beads were then washed twice with GSK3 buffer and sub-
jected to in vitro phosphorylation by incubating at 30º for 30 min
with GSK3 buffer, 100 mM ATP, 12.5 mM MgCl2, 250 U PKA, 50 U
GSK3, and/or 100 U CK1 (NEB) where indicated. Beads were then
washed twice with the Kc cell-lysis buffer for binding reactions
with HA-Slimb cell lysate or CX buffer (50 mM Tris [pH 8], 150 mM
NaCl, 1 mM EDTA, 1% NP-40, 50 mM NaF, 1 mM DTT) for binding re-
actions with 35S-Slimb. Two hundred microliters of Kc cell extract or
8 ml in vitro-translated product was bound to the beads along with 1
mg/ml BSA + 0.5 mM okadaic acid as a phosphatase inhibitor for 2 hr
at 4ºC. Beads were then washed three times and eluted with SDS-
PAGE loading buffer and boiled for 5 min prior to loading. Proteinswere visualized by western blotting with the 3F10 rat anti-HA (Roche)
and rabbit anti-GST primary antibodies. Alexaflour-680 and -800
were used as secondary antibodies and visualized with the LI-COR
Odyssey Infared Imager, which allowed accurate quantitation of
band intensities. 35S-Slimb was visualized by autoradiography.
Immunohistochemistry
Generally, larvae were heat shocked at the second instar for 1 hr at
37ºC to induce clones and then kept at 29º to drive high expression
of proteins expressed from UAS transgenes. At late third instar, lar-
vae were dissected into cold Brower fixation buffer and rocked
at 4ºC for 1 hr. Discs were blocked in PBST + 5% BSA for 1 hr and
then stained by standard methods. hh-lacZ gene product was
stained by using rabbit anti-b-galactosidase antibody (Promega) and
Alexaflour-594 secondary. Full-length Ci transgene products were
stained with Cy3-conjugated mouse monoclonal antibody to Myc
(Amersham).
Wing-Disc Extracts
C765-GAL4 females were crossed to UAS-Ci or UAS-mC*; UAS-Ci
males, and progeny were incubated at 25ºC. Approximately 40 discs
were dissected from late third-instar larvae into cold PBS and centri-
fuged at maximum speed for 30 s. The PBS was aspirated off, and
the discs were lysed in 25 ml SDS-PAGE loading buffer and boiled
for 5 min prior to loading.
Immunoprecipitation from Embryo Extracts
ptc-GAL4 females were crossed to UAS-Ci males to generate
embryos expressing the transgenes. Embryos were collected for
3 hr on apple juice plates and then incubated for 5 hr at 29ºC.
Embryos were dechorionated for 3 min in bleach with shaking,
rinsed for 2 min with PBST, and then decanted into 1.5 ml tubes. Fifty
microliters of embryos were homogenized in 200 ml RIPA/glycerol
buffer (150 mM NaCl, 1% NP-40, 0.5% deoxycholate, 0.13 SDS,
50 mM Tris [pH 8], 1 mM DTT, 10% glycerol, 1 mM EDTA, protease
inhibitors [Mini Complete, Roche], and 0.5 mM okadaic acid) for
1 min at 4ºC. After a 15 min centrifugation at 4ºC, the extracts
were precleared with protein G beads for 1 hr at 4ºC. Immunoprecip-
itation was carried out by incubating with 1 ml 12CA5 HA monoclonal
antibody (in ascites fluid) overnight and then adding protein G beads
for 1 hr at 4ºC. Beads were washed three times with RIPA/glycerol
buffer and eluted with SDS-PAGE loading buffer and boiled for
5 min prior to loading.
Fly Crosses
Females with the genotype ywflp; ubi-GFP FRT40A / Cyo; C765 hh-
lacZ / TM6B were crossed to yw; smo2 UAS-Ci FRT40A / CyO males
to generate smomutant clones or yw; smo2 pka-c1B3 FRT40A / CyO;
UAS-Ci to generate smo pka mutant clones. Females with the geno-
type ywflp; ubi-GFP FRT40A / CyO; FRT82B slimb1 C765 hh-lacZ /
TM6B were crossed to yw; smo2 UAS-Ci FRT40A / CyO; FRT82B
ubi-GFP / TM6B males to generate smo slimb clones.
Supplemental Data
Supplemental Data include one figures and are available with this ar-
ticle online at: http://www.current-biology.com/cgi/content/full/16/
1/110/DC1/.
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